CDH2 and chronic myelogenous leukemia, BCR-ABL1 positive: To test this hypothesis, we detected mRNA levels of N-cadherin and β-catenin from peripheral blood specimens of CML patients (Supplementary Table 1) at different stages of progression (Figures 2C, D).